549 related articles for article (PubMed ID: 29080633)
1. Vitamin D Receptor Signaling and Cancer.
Campbell MJ; Trump DL
Endocrinol Metab Clin North Am; 2017 Dec; 46(4):1009-1038. PubMed ID: 29080633
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
4. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences.
Bandera Merchan B; Morcillo S; Martin-Nuñez G; Tinahones FJ; Macías-González M
J Steroid Biochem Mol Biol; 2017 Mar; 167():203-218. PubMed ID: 27913313
[TBL] [Abstract][Full Text] [Related]
5. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
6. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
[TBL] [Abstract][Full Text] [Related]
7. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
8. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
Boyan BD; Sylvia VL; McKinney N; Schwartz Z
J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
[TBL] [Abstract][Full Text] [Related]
9. [Bone and calcium metabolism associated with malignancy. Vitamin D and cancer.].
Makishima M
Clin Calcium; 2018; 28(11):1465-1472. PubMed ID: 30374002
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
12. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Christakos S; Raval-Pandya M; Wernyj RP; Yang W
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D signaling and the differentiation of developing dopamine systems.
Pertile RA; Cui X; Eyles DW
Neuroscience; 2016 Oct; 333():193-203. PubMed ID: 27450565
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Buchwald PC; Westin G; Akerström G
Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
[TBL] [Abstract][Full Text] [Related]
15. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.
Deeb KK; Trump DL; Johnson CS
Nat Rev Cancer; 2007 Sep; 7(9):684-700. PubMed ID: 17721433
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D receptor as a therapeutic target.
Campbell MJ; Adorini L
Expert Opin Ther Targets; 2006 Oct; 10(5):735-48. PubMed ID: 16981830
[TBL] [Abstract][Full Text] [Related]
19. Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond.
Reichrath J; Saternus R; Vogt T
Mol Cell Endocrinol; 2017 Sep; 453():96-102. PubMed ID: 28526240
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.
Cui X; Pertile R; Liu P; Eyles DW
Neuroscience; 2015 Sep; 304():90-100. PubMed ID: 26210580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
